Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Nona Biosciences Partners with Link Cell on CAR-T Discovery Using HCAb Platform
CompanyDeals

Nona Biosciences Partners with Link Cell on CAR-T Discovery Using HCAb Platform

January 12, 2026
CompanyDrug

Hengrui’s Quadruple Prostate Cancer Combo Wins NMPA IND for Phase 2 Study

January 12, 2026
CompanyDrug

Shanghai Pharma Receives NMPA Approval for Myasthenia Gravis Oral Solution

January 12, 2026
CompanyDrug

FDA Announces Flexible CMC Pathway for Cell and Gene Therapies to Accelerate Development

January 12, 2026
CompanyDrug

Huadong Medicine’s DR10624 Wins Breakthrough Designation for Severe Hypertriglyceridemia

January 12, 2026
Medical Device

Dongcheng Pharma’s PSMA PET Agent [18F] Spiritide NDA Accepted by NMPA

January 12, 2026
Company

Novartis to Build $23 Billion RLT Facility in Florida, Expanding Cancer Therapy Capacity

January 12, 2026
CompanyDeals

Pierre Fabre Partners with Iktos on AI-Driven Oncology Drug Discovery

January 12, 2026
Policy / Regulatory

NHSA Launches Personal Healthcare Insurance Cloud Pilot Program

January 12, 2026
Policy / Regulatory

China Expands Medical Insurance Personal Account Pooling Nationwide

January 12, 2026
Haisco Licenses COPD Drug HSK39004 to AirNexis for $1.06 Billion
CompanyDeals

Haisco Licenses COPD Drug HSK39004 to AirNexis for $1.06 Billion

January 12, 2026
Novartis Secures Exclusive Rights to Zonsen PepLib's Radioligand Asset
CompanyDeals

Novartis Secures Exclusive Rights to Zonsen PepLib’s Radioligand Asset

January 12, 2026
1 2 … 15 16 17 18 19 … 22 23
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up